3-[methyl(2-phenylethyl)amino]-1-propanol | 16210-85-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-[methyl(2-phenylethyl)amino]-1-propanol
• 英文别名: 3-(N-Methylphenethylamino)-1-propanol；3-(methyl-phenethyl-amino)-propan-1-ol；3-(Methyl-phenaethyl-amino)-propan-1-ol；3-[methyl(2-phenylethyl)amino]propan-1-ol
• CAS: 16210-85-8
• 化学式: C₁₂H₁₉NO
• 分子量: 193.289
• InChiKey: DAHNJESETSYGHV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  14
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  23.5
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-[methyl(2-phenylethyl)amino]-1-propanol 、 对氟硝基苯 在 sodium hydride 作用下， 以 氘代二甲亚砜 为溶剂， 反应 2.0h， 生成 Methyl-[3-(4-nitro-phenoxy)-propyl]-phenethyl-amine
  参考文献：
  名称：

  Synthesis, electrophysiological properties and analysis of structural requirements of a novel class of antiarrhythmic agents with potassium and calcium channel blocking properties

  摘要：

  Class III antiarrhythmic agents have been shown to prevent reentrant arrhythmias but also to be responsible for initiating arrhythmias characterised by afterdepolarizations and triggered activities. By combining potassium and calcium channel antagonistic actions, as with BRL-32872(1,2) (1), it might be possible to reduce the incidence of proarrhythmias albeit retaining antiarrhythmic efficacy. In the present study we synthesised and tested for their electrophysiological activity in guinea pig papillary muscle a wide panel of analogues of BRL-32872. Some qualitative relationships between compound structure and the inhibitory effect on the rapidly activating component of the delayed rectifier potassium current and/or the L-type calcium current will be presented. New derivatives depicting bell-shaped dose-response curves on action potential duration may therefore represent novel agents for improved antiarrhythmic therapy. (C) 1998 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0968-0896(98)00166-7
• 作为产物：
  描述：

  N-亚苄基苯乙胺 生成 3-[methyl(2-phenylethyl)amino]-1-propanol
  参考文献：
  名称：

  Phenyl Urethan Anesthetics. II

  摘要：

  DOI：

  10.1021/ja01298a004

文献信息

• Utility of azetidinium methanesulfonates for radiosynthesis of 3-[18F]fluoropropyl amines
  作者：Dale O. Kiesewetter、William C. Eckelman

  DOI：10.1002/jlcr.884

  日期：2004.11

  3-Methanesulfonyloxypropyl tertiary amines were observed to cyclize to form azetidinium methanesulfonate moieties. Heat-induced cyclization of 3-methanesulfonyloxypropyl amines was utilized for preparation of azetidinium methanesulfonates. The azetidinium methanesulfonates were found to incorporate radioactive [18F]fluoride (decay-corrected yields >60%) efficiently, resulting in an efficient synthesis of 3-[18F]fluoropropyl tertiary amines. Copyright © 2004 John Wiley & Sons, Ltd.

  观察到 3-甲磺酰氧基丙基叔胺环化形成甲磺酸氮杂环丁烷。利用 3-甲磺酰氧基丙胺的热诱导环化反应制备了氮杂环丁烷甲磺酸盐。研究发现，氮杂环丁烷甲烷磺酸盐能有效地结合放射性[18F]氟化物（衰变校正产率大于 60%），从而高效合成了 3-[18F]fluoropropyl tertiary amines（3-[18F]氟丙基叔胺）。Copyright © 2004 John Wiley & Sons, Ltd. All Rights Reserved.
• [EN] NEW SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS<br/>[FR] NOUVEAUX DÉRIVÉS DE SPIROCYCLOHEXANE, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT ET LEURS UTILISATIONS COMME INHIBITEURS ANTI-APOPTOTIQUES
  申请人：SERVIER LAB

  公开号：WO2024008941A1

  公开（公告）日：2024-01-11

  Compounds of Formula (I): wherein R1, R2, R3, R4and are as defined in the description. Medicaments.

  式 (I) 的化合物：其中 R1、R2、R3、R4 和如描述中所定义。药物。
• A Modular Strategy for the Synthesis of Macrocycles and Medium-Sized Rings via Cyclization/Ring Expansion Cascade Reactions
  作者：Illya Zalessky、Jack M. Wootton、Jerry K. F. Tam、Dominic E. Spurling、William C. Glover-Humphreys、James R. Donald、Will E. Orukotan、Lee C. Duff、Ben J. Knapper、Adrian C. Whitwood、Theo F. N. Tanner、Afjal H. Miah、Jason M. Lynam、William P. Unsworth

  DOI：10.1021/jacs.4c00659

  日期：2024.2.28

  and medium-sized rings are important in many scientific fields and technologies but are hard to make using current methods, especially on a large scale. Outlined herein is a strategy by which functionalized macrocycles and medium-sized rings can be prepared using cyclization/ring expansion (CRE) cascade reactions, without resorting to high dilution conditions. CRE cascade reactions are designed to operate

  大环和中型环在许多科学领域和技术中都很重要，但使用现有方法很难制造，尤其是大规模制造。本文概述了一种策略，通过该策略可以使用环化/扩环（CRE）级联反应来制备官能化大环和中等大小的环，而不需要采用高稀释条件。 CRE 级联反应专门通过动力学有利的 5-7 元环环化步骤进行操作；这意味着避免了通常与经典的端到端大环化反应相关的问题。已经开发出一种模块化合成方法，以促进所需线性前体的简单组装，然后可以使用九种 CRE 方案之一将其转化为极其广泛的官能化大环化合物和中等大小的环。
• Phenyl Urethan Anesthetics. II
  作者：E. S. Cook、T. H. Rider

  DOI：10.1021/ja01298a004

  日期：1936.7
• Synthesis, electrophysiological properties and analysis of structural requirements of a novel class of antiarrhythmic agents with potassium and calcium channel blocking properties
  作者：Guy Nadler、Jean-François Faivre、Marie-Claire Forest、Brigitte Cheval、Michel Martin、Michel Souchet、Bernard Gout、Antoine Bril

  DOI：10.1016/s0968-0896(98)00166-7

  日期：1998.11

  Class III antiarrhythmic agents have been shown to prevent reentrant arrhythmias but also to be responsible for initiating arrhythmias characterised by afterdepolarizations and triggered activities. By combining potassium and calcium channel antagonistic actions, as with BRL-32872(1,2) (1), it might be possible to reduce the incidence of proarrhythmias albeit retaining antiarrhythmic efficacy. In the present study we synthesised and tested for their electrophysiological activity in guinea pig papillary muscle a wide panel of analogues of BRL-32872. Some qualitative relationships between compound structure and the inhibitory effect on the rapidly activating component of the delayed rectifier potassium current and/or the L-type calcium current will be presented. New derivatives depicting bell-shaped dose-response curves on action potential duration may therefore represent novel agents for improved antiarrhythmic therapy. (C) 1998 Elsevier Science Ltd. All rights reserved.